Methylprednisone Active Not Recruiting Phase 2 Trials for Kidney Transplantation / Coronavirus Disease 2019 (COVID‑19) / Focal Segmental Glomerulosclerosis (FSGS) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02921789Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients